Pharmacologic interventions for weight-related health risks
Evidence-based guidelines for obesity support the use of pharmacologic therapy in collaboration with lifestyle interventions.
Print Issue: October 01, 2014
A different look at lipids
The first step in reducing the risk of cardiovascular disease is for health-care professionals to get a full understanding of a patient’s risk.
Neuropsychiatric woes in Parkinson disease
Approximately two-thirds of patients with Parkinson disease and depression were not taking an antidepressant at any visit.
Breast cancer risk falls with NSAIDs
One study of 6,459 U.S. women aged 55 years to 81 years revealed that the use of alendronate or placebo did not affect the proportion of women who developed breast cancer (1.8% and 1.5%, respectively).
Why your patients seek primary care from the emergency department
Primary-care practitioners should change to accommodate patients seeking primary care from emergency departments.
Discussing advance directives during a patient’s first visit
Doctors should start a dialogue about advance directives upon a patient’s first visit to help them make decisions regarding their health care.
Pain in a person with hepatitis C and a fatty pancreas
An obese patient with chronic hepatitis C, diabetes, advanced cirrhosis, and fatty pancreas presents with chronic right-to-middle upper-abdomen pain.
Craniosacral therapy may be helpful, but not curative
Due to the limited amount of high-quality human studies, craniosacral therapy should not be suggested as a first-line treatment.
Statins cut microvascular risk in diabetes
Compared with patients who had not taken statins, those who had were less likely to develop diabetic neuropathy by 34%, diabetic retinopathy by 40%, and gangrene by 12%.
Patient receives a kidney diagnosis and a life lesson
Patient with back pain and blood in urine is diagnosed with autosomal dominant polycystic kidney disease.
- Loading...
Loading...
Next post in Consultations
Loading... 
Loading...